Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR)

Historical Holders from Q1 2014 to Q3 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Symbol: NKTR on Nasdaq
Shares outstanding: 20,788,527
Price per share: $56.90
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares: 7,254
Total reported value: $412,697
% of total 13F portfolios: 0%
Share change: +806
Value change: +$299,814
Number of holders: 8
Price from insider filings: $56.90

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) based on Schedule 13D/G filings

Filer	Ownership	Holdings Value	Nb Shares	Reporting Name	Report Period
BlackRock, Inc.	6.7%	$9,270,724	12,528,006	BlackRock, Inc.	31 Mar 2025
EVENTIDE ASSET MANAGEMENT, LLC	3.6%	$4,921,000	6,650,000	Eventide Asset Management, LLC	31 Dec 2024
Deep Track Capital, LP	1.1%	$1,462,239	1,975,998	Deep Track Capital, LP	31 Dec 2024

As of 30 Sep 2025, Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) has 8 institutional shareholders filing 13F forms. They hold 7,254 shares. of 20,788,527 outstanding shares (0.03%) .

Institutional Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	7,254	$412,697	+$299,814			$56.90	8
2025 Q2	6,448	$52,906	-$84,345,665	$0	$0	$25.84	7
2025 Q1	123,832,570	$84,191,414	-$9,619,052	$43,928	$800,887	$0.68	156
2024 Q4	132,887,132	$123,564,418	-$10,051,378	$4,557	$84,723	$0.93	144
2024 Q3	140,728,695	$182,906,836	+$5,561,656	$18,330	$42,380	$1.30	138
2024 Q2	135,417,464	$167,916,168	+$31,189,751	$68,820	$40,672	$1.24	132
2024 Q1	112,890,288	$105,437,293	-$4,637,674	$3,737	$139,298	$0.93	117
2023 Q4	119,190,605	$67,330,899	-$14,356,167	$2,599	$5,707	$0.56	119
2023 Q3	143,162,977	$85,280,943	+$3,466,954	$27,874	$4,824	$0.60	130
2023 Q2	137,616,980	$79,156,536	-$21,632,445	$34,455	$317,983	$0.58	138
2023 Q1	172,656,651	$121,134,385	-$6,847,947	$7,802	$458,876	$0.70	187
2022 Q4	169,134,728	$382,214,358	-$28,072,203	$21,696	$24,182	$2.26	209
2022 Q3	175,467,213	$561,862,456	-$30,006,635	$67,000	$333,200	$3.20	208
2022 Q2	182,451,737	$693,387,846	+$14,942,655	$332,000	$1,556,560	$3.80	203
2022 Q1	175,738,382	$947,161,661	-$12,647,310	$23,019,880	$24,343,703	$5.39	217
2021 Q4	173,960,187	$2,350,617,677	+$60,793,716	$22,882,980	$24,713,000	$13.51	225
2021 Q3	167,527,305	$3,008,326,722	-$15,294,872	$6,213,000	$20,645,000	$17.96	228
2021 Q2	167,936,090	$2,881,857,625	-$33,251,989	$9,704,000	$9,623,000	$17.16	231
2021 Q1	169,693,928	$3,392,531,228	-$52,781,602	$6,701,000	$6,972,000	$20.00	224
2020 Q4	172,290,053	$2,929,156,988	-$17,045,988	$6,732,000	$17,494,000	$17.00	232
2020 Q3	175,748,755	$2,915,926,690	-$42,045,853	$7,011,000	$12,075,000	$16.59	238
2020 Q2	174,896,826	$4,050,261,692	-$44,584,638	$14,046,000	$19,012,000	$23.16	249
2020 Q1	177,174,980	$3,164,197,295	+$12,315,614	$13,625,000	$10,564,000	$17.85	234
2019 Q4	175,849,330	$3,795,370,239	-$40,913,708	$26,136,000	$28,692,000	$21.58	270
2019 Q3	178,006,422	$3,241,831,055	+$139,183,084	$23,005,000	$27,904,000	$18.22	272
2019 Q2	165,918,824	$5,899,886,319	+$833,932,879	$60,763,000	$29,198,000	$35.58	327
2019 Q1	162,897,398	$5,472,194,669	-$66,824,317	$41,077,000	$23,151,000	$33.60	340
2018 Q4	164,848,349	$5,418,580,035	+$34,325,427	$42,838,000	$70,248,000	$32.87	322
2018 Q3	159,600,491	$9,729,032,838	-$26,508,318	$113,164,000	$190,139,000	$60.96	375
2018 Q2	160,416,782	$7,832,434,531	-$143,968,898	$92,063,000	$202,165,000	$48.83	368
2018 Q1	157,039,690	$16,679,618,668	+$350,934,157	$144,863,000	$338,309,000	$106.26	349
2017 Q4	154,603,092	$9,233,952,173	+$80,601,155	$25,287,000	$169,331,000	$59.72	261
2017 Q3	153,912,042	$3,692,685,792	+$66,532,732	$7,952,000	$31,130,000	$24.00	203
2017 Q2	151,352,082	$2,959,589,678	+$123,309,771	$8,032,000	$29,363,000	$19.55	196
2017 Q1	146,311,934	$3,432,643,057	+$471,797,573	$9,433,000	$28,677,000	$23.47	198
2016 Q4	145,044,414	$1,779,787,465	+$106,710,874	$4,734,000	$7,889,000	$12.27	196
2016 Q3	133,535,856	$2,292,233,354	-$7,287,187	$4,523,000	$3,955,000	$17.18	189
2016 Q2	134,393,493	$1,912,184,366	-$65,595,760	$2,159,000	$2,503,000	$14.23	171
2016 Q1	139,138,306	$1,913,174,245	-$6,784,614	$2,874,000	$3,119,000	$13.75	172
2015 Q4	139,481,833	$2,350,145,705	-$21,167,934	$3,892,000	$4,917,000	$16.85	177
2015 Q3	141,683,540	$1,552,778,761	+$30,862,779	$3,052,000	$3,120,000	$10.96	165
2015 Q2	138,173,841	$1,728,114,850	+$152,141,225	$4,111,000	$4,955,000	$12.51	177
2015 Q1	126,069,547	$1,386,834,636	+$59,685,451	$4,723,000	$8,984,000	$11.00	152
2014 Q4	120,120,654	$1,861,694,087	+$32,166,353	$1,958,000	$3,625,000	$15.50	162
2014 Q3	118,403,758	$1,429,229,131	+$50,525,687	$1,881,000	$10,030,000	$12.07	144
2014 Q2	114,184,350	$1,463,381,133	-$20,592,506	$3,608,000	$16,742,000	$12.82	141
2014 Q1	115,845,050	$1,403,687,024	+$164,733,234	$2,885,000	$6,657,000	$12.12	138